Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis

Prostate

Volumn 69, Issue 15, 2009, Pages 1603-1610

  Singh, Swaroop S ^a   Mehedint, Diana C ^b   Ford III, O Harris ^b   Jeyaraj, D Antony ^b   Pop, Elena A ^b   Maygarden, Susan J ^c   Ivanova, Anastasia ^b,d   Chandrasekhar, Rameela ^a,e   Wilding, Gregory E ^a,e   Mohler, James L ^a,b,c,f  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

Author keywords

ACINUS; Apoptosis; Image analysis; Tumor growth rate; TUNEL

Indexed keywords

APOPTOPIC CHROMATIN CONDENSATION INDUCER IN THE NUCLEUS; APOPTOSIS INDUCING FACTOR; CASPASE 3; KI 67 ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER TISSUE; CELL NUCLEUS; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; GROWTH CURVE; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; NICK END LABELING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE TUMOR; PROTEIN LOCALIZATION; TUMOR GROWTH; TUMOR LOCALIZATION;

APOPTOSIS; BIOPSY; CASPASE 3; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LOGISTIC MODELS; MALE; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 70349504370     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21019     Document Type: Article

References (22)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26(4):239-257.
2. Miyata Y, Kanda S, Sakai H, Hakariya T, Kanetake H. Relationship between changes in prostate cancer cell proliferation, apoptotic index, and expression of apoptosis-related proteins by neoadjuvant hormonal therapy and duration of such treatment. Urology 2005;65(6):1238-1243. (Pubitemid 40824938)
3. Bladou F, Vessella RL, Buhler KR, Ellis WJ, True LD, Lange PH. Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration. Int J Cancer 1996;67:785-790. (Pubitemid 26348806)
4. Dachille G, Cai T, Ludovico GM, Vestita G, Pagliarulo G, Nesi G, Mazzoli S, Meacci F, Mondaini N, Detti B, Bartoletti R. Prognostic role of cell apoptotic rate in prostate cancer: Outcome of a long-time follow-up study. Oncol Rep 2008;19(2):541-545. (Pubitemid 351176118)
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin 2008;58:71-96.
6. Schroeder JC, Bensen JT, Su LJ, Mishel M, Ivanova A, Smith GJ, Godley PA, Fontham ET, Mohler JL. The North Carolina-Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate 2006;66(11):1162- 1176. (Pubitemid 44175339)
7. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715. (Pubitemid 14035254)
8. Bettencourt MC, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JW. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol 1996;156(3):1064-1068.
9. Stattin P, Damber JE, Karlberg L, Bergh A. Cell proliferation assessed by Ki-67 immunoreactivity on formalinfixed tissues is a predictive factor for survival in prostate cancer. J Urol 1997;157(1):219-222. (Pubitemid 26414962)
10. Sahara S, Aoto M, Eguchi Y, Imamoto N, Yoneda Y, Tsujimoto Y. ACINUS is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 1999;401(6749):168-173. (Pubitemid 29436320)
11. Bellamy CO, Malcomson RD, Harrison DJ, Wyllie AH. Cell death in health and disease: The biology and regulation of apoptosis. Semin Cancer Biol 1995;6(1):3-16.
12. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119(3):493-501.
13. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391(6662):43-50. (Pubitemid 28079208)
14. Henery S, George T, Hall B, Basiji D, Ortyn W, Morrissey P. Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: A comparison with standard photometric methods. Apoptosis 2008;13(8):1054-1063.
15. Singh SS, Kim D, Mohler JL. Java Web Start based software for automated quantitative nuclear analysis of prostate cancer and benign prostate hyperplasia. Biomed Eng Online 2005;4:31. (Pubitemid 41613896)
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44(3):837-845.
17. Arends MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol 1994;144(5):1045-1057.
18. Stein WD, Figg WD, Dahut W, Stein AD, Hoshen MB, Price D, Bates SE, Fojo T. Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: A novel strategy for evaluation of clinical trial data. Oncologist 2008;13(10):1046-1054.
19. Sheridan MT, Cooper RA, West CM. A high ratio of apoptosis to proliferation correlates with improved survival after radiotherapy for cervical adenocarcinoma. Int J Radiat Oncol Biol Phys 1999;44; 507-512.
20. Koike M. Significance of spontaneous apoptosis during colorectal tumorigenesis. J Surg Oncol 1996;62(2):97-108. (Pubitemid 26196506)
21. Kuriyama H, Lamborn KR, O'Fallon JR, Iturria N, Sebo T, Schaefer PL, Scheithauer BW, Buckner JC, Kuriyama N, Jenkins RB, Israel MA. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas. Neuro Oncol 2002;4(3):179-186. (Pubitemid 35214754)
22. Harrison DJ. Counting apoptosis - Why and how? J Clin Path Mol Pathol 1996;49:M245-M246.